This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.
Just recently, Silicon Valley TMS just announced they will be the first practice in Northern Californa that will offer patient access to BrainsWay’s TMS therapy for OCD. Silicon Valley TMS is committed to helping those in the local surrounding communities living with mental illnesses.